Literature DB >> 21812425

Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.

Crina M Orac1, Shu Zhou, John A Means, David Boehm, Stephen C Bergmeier, Jennifer V Hines.   

Abstract

The enantiomers and the cis isomers of two previously studied 4,5-disubstituted oxazolidinones have been synthesized, and their binding to the T-box riboswitch antiterminator model RNA has been investigated in detail. Characterization of ligand affinities and binding site localization indicates that there is little stereospecific discrimination for binding antiterminator RNA alone. This binding similarity between enantiomers is likely due to surface binding, which accommodates ligand conformations that result in comparable ligand-antiterminator contacts. These results have significant implications for T-box antiterminator-targeted drug discovery and, in general, for targeting other medicinally relevant RNA that do not present deep binding pockets.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812425      PMCID: PMC3466060          DOI: 10.1021/jm2006904

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  30 in total

1.  Python: a programming language for software integration and development.

Authors:  M F Sanner
Journal:  J Mol Graph Model       Date:  1999-02       Impact factor: 2.518

Review 2.  RNA as a drug target.

Authors:  Martin J Drysdale; Georg Lentzen; Natalia Matassova; Alastair I H Murchie; Fareed Aboul-Ela; Mohammad Afshar
Journal:  Prog Med Chem       Date:  2002

Review 3.  Interplay between microRNAs and the epigenetic machinery: an intricate network.

Authors:  Marilena V Iorio; Claudia Piovan; Carlo M Croce
Journal:  Biochim Biophys Acta       Date:  2010-05-20

4.  In-line probing analysis of riboswitches.

Authors:  Elizabeth E Regulski; Ronald R Breaker
Journal:  Methods Mol Biol       Date:  2008

5.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

Authors:  M D Eldridge; C W Murray; T R Auton; G V Paolini; R P Mee
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

6.  In vitro structure-function studies of the Bacillus subtilis tyrS mRNA antiterminator: evidence for factor-independent tRNA acceptor stem binding specificity.

Authors:  Melinda S Gerdeman; Tina M Henkin; Jennifer V Hines
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

7.  A method for the parallel synthesis of multiply substituted oxazolidinones.

Authors:  Stephen C Bergmeier; Steven J Katz
Journal:  J Comb Chem       Date:  2002 Mar-Apr

8.  Structure-activity studies of oxazolidinone analogs as RNA-binding agents.

Authors:  John Means; Steven Katz; Abhijit Nayek; Rajaneesh Anupam; Jennifer V Hines; Stephen C Bergmeier
Journal:  Bioorg Med Chem Lett       Date:  2006-04-05       Impact factor: 2.823

9.  Synthesis of Vicinal Amino Alcohols via a Tandem Acylnitrene Aziridination-Aziridine Ring Opening.

Authors:  Stephen C. Bergmeier; Dionne M. Stanchina
Journal:  J Org Chem       Date:  1997-06-27       Impact factor: 4.354

10.  Identification of neomycin B-binding site in T box antiterminator model RNA.

Authors:  Rajaneesh Anupam; Leyna Denapoli; Abigael Muchenditsi; Jennifer V Hines
Journal:  Bioorg Med Chem       Date:  2008-03-07       Impact factor: 3.641

View more
  15 in total

1.  Anisotropy studies of tRNA-T box antiterminator RNA complex in the presence of 1,4-disubstituted 1,2,3-triazoles.

Authors:  S Zhou; G Acquaah-Harrison; S C Bergmeier; J V Hines
Journal:  Bioorg Med Chem Lett       Date:  2011-09-29       Impact factor: 2.823

2.  T box riboswitches in Actinobacteria: translational regulation via novel tRNA interactions.

Authors:  Anna V Sherwood; Frank J Grundy; Tina M Henkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

3.  Small molecule-RNA targeting: starting with the fundamentals.

Authors:  Amanda E Hargrove
Journal:  Chem Commun (Camb)       Date:  2020-11-26       Impact factor: 6.222

4.  RNA drug discovery: Conformational restriction enhances specific modulation of the T-box riboswitch function.

Authors:  Ian Armstrong; Ali H Aldhumani; Jia L Schopis; Fang Fang; Eric Parsons; Chunxi Zeng; Md Ismail Hossain; Stephen C Bergmeier; Jennifer V Hines
Journal:  Bioorg Med Chem       Date:  2020-08-06       Impact factor: 3.641

Review 5.  An evolving tale of two interacting RNAs-themes and variations of the T-box riboswitch mechanism.

Authors:  Krishna C Suddala; Jinwei Zhang
Journal:  IUBMB Life       Date:  2019-06-17       Impact factor: 3.885

6.  Ligand-induced changes in T box antiterminator RNA stability.

Authors:  Shu Zhou; George Acquaah-Harrison; Karen D Jack; Stephen C Bergmeier; Jennifer V Hines
Journal:  Chem Biol Drug Des       Date:  2011-12-22       Impact factor: 2.817

Review 7.  The T box riboswitch: A novel regulatory RNA that utilizes tRNA as its ligand.

Authors:  Tina M Henkin
Journal:  Biochim Biophys Acta       Date:  2014-05-09

8.  Factors that influence T box riboswitch efficacy and tRNA affinity.

Authors:  C Zeng; S Zhou; S C Bergmeier; J V Hines
Journal:  Bioorg Med Chem       Date:  2015-07-16       Impact factor: 3.641

9.  Identification of Spermidine Binding Site in T-box Riboswitch Antiterminator RNA.

Authors:  Jia Liu; Chunxi Zeng; Vivian Hogan; Shu Zhou; Md Masud Monwar; Jennifer V Hines
Journal:  Chem Biol Drug Des       Date:  2015-10-05       Impact factor: 2.817

10.  Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR.

Authors:  Neeraj N Patwardhan; Laura R Ganser; Gary J Kapral; Christopher S Eubanks; Janghyun Lee; Bharathwaj Sathyamoorthy; Hashim M Al-Hashimi; Amanda E Hargrove
Journal:  Medchemcomm       Date:  2017-03-15       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.